REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Malaysia Pharma and Healthcare Sector Report 2019/2020

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: January 2020
Pages: 84
Available in: English

Malaysia has one of the most developed pharmaceuticals and healthcare sectors in the ASEAN region. The country operates a dual public-private healthcare system in which the government, under the Ministry of Health (“MoH”), both regulates the entire pharmaceuticals and healthcare sector and provides taxpayer-subsidised healthcare services to citizens. Private healthcare providers supplement the public healthcare system for Malaysians who can afford their fees, and also for a growing medical tourist base. Malaysia is a significant producer in some segments of the medical devices and pharmaceuticals subsectors, notably rubber gloves, catheters, and halal pharmaceuticals, but the country is still import-dependent in many important segments.  

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Malaysia . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Malaysia
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Malaysia
  • Crystallise the forces both driving and restraining this sector in Malaysia
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Malaysia
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

 

See below for a complete table of report contents:

Malaysia Pharma and Healthcare Sector Report 2019/2020 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Malaysia Pharma and Healthcare Sector Report 2019/2020 -  Page 3
Malaysia Pharma and Healthcare Sector Report 2019/2020 -  Page 4
Malaysia Pharma and Healthcare Sector Report 2019/2020 -  Page 19
Malaysia Pharma and Healthcare Sector Report 2019/2020 -  Page 20
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?